These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 2966565
1. Impact of different reperfusion modalities on ventricular function after acute myocardial infarction. O'Neill WW. Am J Cardiol; 1988 May 09; 61(14):45G-53G. PubMed ID: 2966565 [Abstract] [Full Text] [Related]
4. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty. Bruna C, Rossetti G, Vado A, Racca E, Steffenino G, Dellavalle A, Ribichini F, Ferrero V, Menardi E, Uslenghi E. G Ital Cardiol; 1998 Jan 09; 28(1):3-11. PubMed ID: 9493040 [Abstract] [Full Text] [Related]
10. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy. Waller BF, Rothbaum DA, Pinkerton CA, Cowley MJ, Linnemeier TJ, Orr C, Irons M, Helmuth RA, Wills ER, Aust C. J Am Coll Cardiol; 1987 Apr 09; 9(4):785-801. PubMed ID: 2951422 [Abstract] [Full Text] [Related]
12. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Van Natta P, Passamani ER, Williams DO, Zaret B. Circulation; 1987 Apr 09; 75(4):817-29. PubMed ID: 3103950 [Abstract] [Full Text] [Related]
13. Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction. Magnani B. J Am Coll Cardiol; 1989 Jan 09; 13(1):19-26. PubMed ID: 2491867 [Abstract] [Full Text] [Related]
17. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). Tiefenbrunn AJ, Chandra NC, French WJ, Gore JM, Rogers WJ. J Am Coll Cardiol; 1998 May 09; 31(6):1240-5. PubMed ID: 9581714 [Abstract] [Full Text] [Related]
18. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC. N Engl J Med; 1993 Mar 11; 328(10):673-9. PubMed ID: 8433725 [Abstract] [Full Text] [Related]
19. Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial. Erbel R, Pop T, Henrichs KJ, von Olshausen K, Schuster CJ, Rupprecht HJ, Steuernagel C, Meyer J. J Am Coll Cardiol; 1986 Sep 11; 8(3):485-95. PubMed ID: 2943780 [Abstract] [Full Text] [Related]
20. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. Dalen JE, Gore JM, Braunwald E, Borer J, Goldberg RJ, Passamani ER, Forman S, Knatterud G. Am J Cardiol; 1988 Aug 01; 62(4):179-85. PubMed ID: 3135737 [Abstract] [Full Text] [Related] Page: [Next] [New Search]